Phoenix PharmaLabs

Phoenix PharmaLabs is addressing the opioid crisis by developing a potent, safe, non-addictive painkiller.


see other companies in category:

Phoenix PharmaLabs Website

minimum raise


maximum raise


start date


stop date


security type

Common Stock

investment minimum


raised to date


reporting date


number of investors

Not Known

percent of minimum raised


percent of maximum raised


likelihood of reaching max

Likely to Reach Max

dollars per day to reach max


dollars per day committed


dollars per day - category-


dollars per day committed - all companies

More SEC Filing Data on Phoenix PharmaLabs from

Phoenix PharmaLabs has created a safe and non-addictive painkiller that they hope will combat the opioid epidemic and crisis. This preclinical, potent treatment can be used for both pain and addiction treatment. So far, it’s been tested in animal studies to be effective, does not produce withdrawal, does not cause death from overdose, and does not cause constipation. The US Army and the NIH have already been provided a $3M grant, and with this campaign, Phoenix PharmaLabs hopes to accelerate the advancement of the drug and perform key studies in humans.